On June 13, 2022, the biotechnology company Thermo Fisher Scientific Inc. announced that its two new diagnostic blood tests – one for lupus and one for systemic sclerosis – were approved by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback